Article info
Poster Session
Adaptive immunity and lymphocytes
48 Ixazomib, an oral proteasome inhibitor, reduces antibody production by depleting plasma cells in a t cell dependent antigen response model
Citation
48 Ixazomib, an oral proteasome inhibitor, reduces antibody production by depleting plasma cells in a t cell dependent antigen response model
Publication history
- First published March 24, 2017.
Online issue publication
March 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions